Finished

Effect of Papaverine on Renal Artery Blood Flow Volume

NCT04162834 · Asan Medical Center · Updated 19 April 2021

What is being tested: Papaverine; Normal saline
For: Kidney Cancer
Kind of study: Tests a treatment or device on volunteers. Phase 4.
Who can join: Ages 20 years to 79 years. About 96 people. The full rules are on the registry page.
Where: South Korea
When: Starts or started 21 Nov 2019, ends 15 April 2021. Registered 14 Nov 2019.
Results: None posted yet.

In the researchers' words

The purpose of this study is to evaluate the effect of papaverine on renal artery blood flow after declamping of renal artery.

Sites